Banmeet Anand Selected Research

ASG-5ME

10/2019

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Banmeet Anand Research Topics

Disease

1	Fatigue 10/2019
1	Exanthema (Rash) 10/2019
1	Prostatic Neoplasms (Prostate Cancer) 10/2019
1	Hypoxia (Hypoxemia) 10/2019
1	Neutropenia 10/2019
1	Hyponatremia 10/2019
1	Abdominal Pain (Pain, Abdominal) 10/2019
1	Diarrhea 10/2019
1	Constipation 10/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Rheumatoid Arthritis 01/2011
1	Virus Diseases (Viral Diseases) 03/2003
1	Herpes Simplex 03/2003
1	Infections 03/2003

Drug/Important Bio-Agent (IBA)

2	Immunoconjugates (Immunoconjugate)IBA 10/2019 - 01/2018
1	monomethyl auristatin EIBA 10/2019
1	auristatinIBA 10/2019
1	ASG-5MEIBA 10/2019
1	TroponinIBA 10/2019
1	AGS-16C3FIBA 01/2018
1	monomethylauristatin FIBA 01/2018
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018
1	PyrophosphatasesIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2011
1	Antiviral Agents (Antivirals)IBA 03/2003
1	valyltyrosineIBA 03/2003
1	ProdrugsIBA 03/2003
1	Acyclovir (Aciclovir)FDA LinkGeneric 03/2003
1	valylvaline (Val-Val)IBA 03/2003
1	Pharmaceutical PreparationsIBA 03/2003
1	DipeptidesIBA 03/2003

Therapy/Procedure

1	Castration 10/2019